Literature DB >> 30859328

Targeting Barriers of Systems of Care in a Growing Multi-disciplinary Field.

Tolulope A Agunbiade1, Yvonne Ottaviano2, Debolina Goswami3, George Ruiz1, Ana Barac4.   

Abstract

PURPOSE OF REVIEW: Cardio-oncology is a growing multi-disciplinary field that focuses on treating and preventing cardiovascular complications in cancer survivors and patients. This review summarizes the current clinical needs and system-based approaches to target barriers of care. RECENT
FINDINGS: The field of cardio-oncology has experienced significant growth in recent years, and an increasing number of programs have been developed across the nation to provide improved and multi-disciplinary care to this patient population. Despite this burgeoning growth, practitioners in the field continue to face important challenges which include lack of administrative and departmental support, funding limitations, and gaps in the areas of mentoring, education, and research. Despite continued growth, cardio-oncology providers continue to face a multitude of challenges. Early inclusion of multi-disciplinary stakeholders, oncologists, cardiovascular team members, and administrative leadership provides an opportunity to collaborate and achieve unique patient care and health system benefits, such as prevention of adverse cardiovascular outcomes, and facilitates the delivery of optimal oncologic treatment.

Entities:  

Keywords:  Cardio-oncology; Cardiovascular disease; Chemotherapy; Oncology; Radiation therapy; Targeted therapy

Mesh:

Year:  2019        PMID: 30859328     DOI: 10.1007/s11912-019-0785-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  21 in total

1.  Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines.

Authors:  D Bovelli; G Plataniotis; F Roila
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10       Impact factor: 6.875

3.  Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.

Authors:  Gregory T Armstrong; Kevin C Oeffinger; Yan Chen; Toana Kawashima; Yutaka Yasui; Wendy Leisenring; Marilyn Stovall; Eric J Chow; Charles A Sklar; Daniel A Mulrooney; Ann C Mertens; William Border; Jean-Bernard Durand; Leslie L Robison; Lillian R Meacham
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

4.  Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience.

Authors:  Valentina Guarneri; Daniel J Lenihan; Vicente Valero; Jean-Bernard Durand; Kristine Broglio; Kenneth R Hess; Laura Boehnke Michaud; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Francisco J Esteva
Journal:  J Clin Oncol       Date:  2006-08-14       Impact factor: 44.544

Review 5.  Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.

Authors:  Ana Barac; Gillian Murtagh; Joseph R Carver; Ming Hui Chen; Andrew M Freeman; Joerg Herrmann; Cezar Iliescu; Bonnie Ky; Erica L Mayer; Tochi M Okwuosa; Juan Carlos Plana; Thomas D Ryan; Anne K Rzeszut; Pamela S Douglas
Journal:  J Am Coll Cardiol       Date:  2015-06-30       Impact factor: 24.094

6.  Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Authors:  Sandra M Swain; Fredrick S Whaley; Michael S Ewer
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

7.  Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.

Authors:  Thomas M Suter; Marion Procter; Dirk J van Veldhuisen; Michael Muscholl; Jonas Bergh; Chiara Carlomagno; Timothy Perren; Rodolfo Passalacqua; Claudia Bighin; Jan G M Klijn; Fail T Ageev; Erika Hitre; Juergen Groetz; Hiroji Iwata; Malgorzata Knap; Michael Gnant; Susanne Muehlbauer; Alison Spence; Richard D Gelber; Martine J Piccart-Gebhart
Journal:  J Clin Oncol       Date:  2007-07-23       Impact factor: 44.544

Review 8.  Evaluation and management of patients with heart disease and cancer: cardio-oncology.

Authors:  Joerg Herrmann; Amir Lerman; Nicole P Sandhu; Hector R Villarraga; Sharon L Mulvagh; Manish Kohli
Journal:  Mayo Clin Proc       Date:  2014-09       Impact factor: 7.616

Review 9.  Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.

Authors:  Edward T H Yeh; Courtney L Bickford
Journal:  J Am Coll Cardiol       Date:  2009-06-16       Impact factor: 24.094

10.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.